No. CBD is not the same as marijuana.
CBD (cannabidiol) can come from the hemp plant, which is legally different from marijuana. Hemp is required by federal law to contain very low levels of THC (the compound that causes impairment). So while CBD and marijuana both come from the cannabis plant family, they are not the same product, not the same experience, and not used the same way.

Key Differences

• CBD (Hemp) → Non-intoxicating, used for comfort and wellness
• Marijuana → Contains higher THC, can cause impairment
• CBD ≠ “getting high” — it does not create the same psychoactive effects

Why do people get them confused?

They both come from the cannabis plant family, just like lemons and limes are both citrus—but they’re not the same fruit. Hemp and marijuana are simply different varieties with different purposes.

Cannabidiol (CBD) is a non-intoxicating cannabinoid derived from hemp that interacts with multiple biological pathways, including the endocannabinoid system, inflammatory signaling, and neurotransmitter modulation. Unlike THC, CBD does not produce euphoria or impairment.

General starting approach should be:

• Start with a low amount (e.g., 5–10 mg)
• Stay at that level for several days
• Increase only if needed

This helps you find your “sweet spot” without taking more than necessary.

Give it time to work...

Oral CBD is not instant. It has to:

• Digest
• Absorb
• Circulate

Timing seniors often report:

• 30–90 minutes to feel initial effects
• More noticeable benefit after several days of consistent use

Consistency matters more than taking a lot all at once.

It can interact with some medications

This does not mean seniors can’t use CBD — but it does mean checking is smart.

If someone is taking medications processed by the liver (like blood thinners, heart medications, or cholesterol meds), CBD may affect how those medications are metabolized.

Simple rule of thumb:
If a doctor or pharmacist has ever said, “Avoid grapefruit with this medication,” then check before adding CBD.

What matters most is knowing what’s in the product.

Seniors should look for:

• A COA (lab test) for every batch
• THC levels clearly listed (especially if avoiding impairment)
• Clear serving size instructions
• Ingredients they can actually recognize

If a product doesn’t provide a lab test → skip it.

All Basic Jane products are tested.

CBD is non-intoxicating and non-impairing, with a distinct safety and regulatory profile. THC produces psychoactive effects and is regulated differently under federal and state law. This is due to different receptor interactions in the body.

Available human data and real-world use suggest CBD is generally well tolerated when used at conservative doses. Reported adverse effects are typically mild and may include fatigue, gastrointestinal discomfort, or changes in appetite. Caution is advised in patients with complex medical conditions or polypharmacy.

CBD may be used intermittently or as part of a daily regimen depending on indication, formulation, and patient response. Conservative initiation and titration are recommended.

CBD can affect cytochrome P450 (CYP450) enzymes, similar to grapefruit. Providers should monitor patients taking medications with narrow therapeutic windows, including certain anticoagulants, antiepileptics, and sedatives. Dose adjustments or increased monitoring may be appropriate. Oral and transdermal delivery methods will carry a risk for DDI. Drugs.com has a list of potential drug-drug interactions https://www.drugs.com/drug-interactions/cannabidiol.html?utm_source=chatgpt.com

At a high level:

• Topicals: Localized application with minimal systemic exposure
• Oral (oils, chews): Systemic effects, slower onset, longer duration
• Transdermal patches: Sustained delivery over time
• Sublingual/mints: Rapid absorption and predictable onset

Selection should align with clinical goals and patient preferences. More detail is provided below.

Topicals (Creams, Gels, Sprays)

Fast, targeted support — applied only where you need it.

• Begin working quickly compared to other formats
• Support is focused on the specific area where applied
• Generally lasts around up to 4 hours depending on use
• Ideal for knees, hands, back, shoulders, or activity-related discomfort
• Great first step for seniors who want on-demand, non-overwhelming relief

Best for: localized discomfort, daily mobility, post-activity support

Oral Products (Capsules, Gummies and mints)

Whole-body support that lasts longer.

• Absorbed through digestion and may support the body more broadly
• Typically take longer to notice (30–90 minutes)
• Effects may last up to 6–8 hours depending on metabolism
• Helpful for seniors looking for routine comfort or sleep support
• “Start low and go slow” is the best approach for finding the right fit

Best for: sleep routines, whole-body balance, consistent daily support

Transdermal Patches

Extended relief with either targeted or full-body support.

• Absorb gradually through the skin for up to 12 hours of steady relief
• Can be placed directly on the area for strong localized support
• Can also be applied to venous areas (inner arm, back, shoulder) for more systemic benefit
• Helpful for seniors who want continuing support without reapplying products

Best for: chronic, recurring discomfort; longer outings; overnight use

Evidence supporting CBD use for pain, anxiety, and sleep is evolving. While available data suggest potential benefit and favorable tolerability, especially compared with some traditional therapies, large randomized controlled trials in older adult populations remain limited. CBD should be considered as an adjunctive option within individualized care plans. Here is a list of some of the research that has been done to date (this should not be considered to be a complete analysis of all literature)

1. Blessing EM, Steenkamp MM, Manzanares J, Marmar CR.
   Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics. 2015;12(4):825-836. doi:10.1007/s13311-015-0387-1
2. Shannon S, Lewis N, Lee H, Hughes S.
   Cannabidiol in anxiety and sleep: A large case series. Perm J. 2019;23:18-041. doi:10.7812/TPP/18-041
3. Cásedas G, Les F, Choya-Foces C, et al.
   Cannabidiol: A potential therapeutic agent for pain and inflammation.
   Biomed Pharmacother. 2020;129:110486. doi:10.1016/j.biopha.2020.110486
4. Moltke J, Hindocha C.
   Reasons for cannabidiol use: A cross-sectional study of CBD users.
   Cannabis Cannabinoid Res. 2021;6(3):257-266. doi:10.1089/can.2020.0060
5. Stockings E, Zagic D, Campbell G, et al.
   Evidence for cannabis and cannabinoids for chronic non-cancer pain: A systematic review. PLoS Med. 2018;15(7):e1002603. doi:10.1371/journal.pmed.1002603
   (Includes CBD-dominant formulations; highlights safety considerations in older adults)
6. Lattanzi S, Brigo F, Trinka E, et al.
   Efficacy and safety of cannabidiol in epilepsy: A systematic review and meta-analysis. Drugs. 2018;78(17):1791-1804. doi:10.1007/s40265-018-0992-5
7. Skelley JW, Deas CM, Curren Z, Ennis J.
   Use of cannabidiol in anxiety and anxiety-related disorders. J Am Pharm Assoc (2003). 2020;60(1):253-261. doi:10.1016/j.japh.2019.11.008
8. Abuhasira R, Schleider LB-L, Mechoulam R, Novack V. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. Eur J Intern Med. 2018;49:44-50. doi:10.1016/j.ejim.2018.01.019
9. Vandrey R, Raber JC, Raber ME, Douglass B, Miller C, Bonn-Miller MO.
   Cannabinoid dose and label accuracy in edible medical cannabis products.
   JAMA. 2015;313(24):2491-2493. doi:10.1001/jama.2015.6613
10. Häuser W, Petzke F, Fitzcharles MA.
    Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management.
    Eur J Pain. 2018;22(3):455-470. doi:10.1002/ejp.1123
11. Babson KA, Sottile J, Morabito D.
    Cannabis, cannabinoids, and sleep: A review of the literature.
    Curr Psychiatry Rep. 2017;19(4):23. doi:10.1007/s11920-017-0775-9

CBD does not carry the same gastrointestinal, renal, or dependency risks associated with long-term NSAID or opioid use. It may be considered as a complementary option, particularly in patients seeking non-opioid approaches.

When CBD may fit well: localized musculoskeletal pain (topicals), mild sleep disturbance, situational anxiety—especially when the goal is to avoid escalation of sedating meds.

When caution is highest: frailty, fall risk, cognitive impairment, hepatic disease, and polypharmacy—especially anticoagulants and CNS depressants.

Documentation tip: note formulation, dose, frequency, indication, and monitoring plan (sleep quality, pain function, sedation/falls, med interactions).

CBD should be used cautiously in patients with significant hepatic impairment, complex polypharmacy, or heightened sensitivity to supplements. Individual risk assessment is recommended.

Topical (Creams, gels and sprays)

Fast, targeted support — applied only where you need it.

• Begin working quickly compared to other formats
• Support is focused on the specific area where applied
• Generally lasts around up to 4 hours depending on use
• Ideal for knees, hands, back, shoulders, or activity-related discomfort
• Great first step for seniors who want on-demand, non-overwhelming relief

Best for: localized discomfort, daily mobility, post-activity support

Oral Products (Capsules, chews and mints)

Whole-body support that lasts longer.

• Absorbed through digestion and may support the body more broadly
• Typically take longer to notice (30–90 minutes)
• Effects may last up to 6–8 hours depending on metabolism
• Helpful for seniors looking for routine comfort or sleep support
• “Start low and go slow” is the best approach for finding the right fit

Best for: sleep routines, whole-body balance, consistent daily support

Transdermal patches

Extended relief with either targeted or full-body support.

• Absorb gradually through the skin for up to 12 hours of steady relief
• Can be placed directly on the area for strong localized support
• Can also be applied to venous areas (inner arm, back, shoulder) for more systemic benefit
• Helpful for seniors who want continuing support without reapplying products

Best for: chronic, recurring discomfort; longer outings; overnight use

Oral CBD products—like oils, capsules, gummies, or softgels—work differently than topicals. They go through the digestive system and may affect the body more broadly. Basic Jane offer CBD mints and chews. For seniors using or considering CBD, here are the key things to know:

Start low and go slow....

Everyone absorbs CBD differently, especially as we age.
Bodies change, metabolisms slow, and sensitivities increase, so it’s best to begin small.

General starting approach should be:

• Start with a low amount (e.g., 5–10 mg)
• Stay at that level for several days
• Increase only if needed

This helps you find your “sweet spot” without taking more than necessary.

Give it time to work...

Oral CBD is not instant. It has to:

• Digest
• Absorb
• Circulate

Timing seniors often report:

• 30–90 minutes to feel initial effects
• More noticeable benefit after several days of consistent use

Consistency matters more than taking a lot all at once.

It can interact with some medications

This does not mean seniors can’t use CBD — but it does mean checking is smart.

If someone is taking medications processed by the liver (like blood thinners, heart medications, or cholesterol meds), CBD may affect how those medications are metabolized.

Simple rule of thumb:
If a doctor or pharmacist has ever said, “Avoid grapefruit with this medication,” then check before adding CBD.

What matters most is knowing what’s in the product.

Seniors should look for:

• A COA (lab test) for every batch
• THC levels clearly listed (especially if avoiding impairment)
• Clear serving size instructions
• Ingredients they can actually recognize

If a product doesn’t provide a lab test → skip it.

All Basic Jane products are tested.

For seniors with specific spots of discomfort (knees, hands, back), topical CBD is popular because:

• It stays where you put it
• It doesn’t circulate through the whole body
• It can be paired with carriers (like menthol, MSM, or alcohol) that help absorption

This is often why seniors prefer creams, gels, and sprays instead of gummies or oils. Topical products work quick within minutes and last roughly 4 hours.

Read Article from Fierce Healthcare "CMS unveils new Medicare pilot for hemp, CBD products"

CMS "Substance Access Beneficiary Engagement Incentive"

Whitehouse Announcement "INCREASING MEDICAL MARIJUANA AND CANNABIDIOL RESEARCH"

Marijuana Moment article "Feds Finalize New Rule Allowing Some Hemp Products As Medicare Advantage Benefits"

Health Exec article "Healthcare agencies mellow on medical cannabis as CMS launches Medicare hemp pilot"

Axios article "Medicare dips a toe into hemp for seniors"

Yes — seniors are at the heart of why Basic Jane exists.

Basic Jane began when our co-founder Kersten’s mother, a senior living with arthritis in her knees, needed relief that actually helped her stay active. We formulated our very first products specifically for her—to support pain, mobility, and everyday comfort without anything harsh, overwhelming, or complicated to use.

From that moment on, seniors have shaped our mission.

A brand built with seniors in mind

Today, more than 60% of Basic Jane customers are over the age of 55. Their feedback directly influences how we:

• Formulate each product for comfort and ease of use
• Test absorption and consistency for predictable relief
• Manufacture with purity, traceability, and clean ingredients
• Choose carriers that help CBD actually reach where it needs to go

Our products didn’t start in a boardroom—they started in a real family, for a real need. And that continues to guide us.

Basic Jane provides:

• Transparent testing and manufacturing data
• Provider-focused education resources
• Clear formulation differentiation to support clinical decision-making

Physicians and healthcare providers can find official information on the CMS Substance Access Beneficiary Engagement Incentive (BEI) program—including eligibility, requirements, and implementation details—on the CMS website: https://www.cms.gov/priorities/innovation/substance-access-beneficiary-engagement-incentive

This CMS page outlines how participating ACO REACH and EOM organizations may incorporate eligible hemp-derived CBD products into clinician-guided care plans, along with key safeguards and program requirements.

The FDA has given guidance at https://www.fda.gov/media/191782/download?attachment